Faculty Information - Sugimoto Naoki

（Last updated : 2024-03-26 17:52:02）

Sugimoto Naoki
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Internal Medicine, Division of Rheumatology

Position

■ Published papers

1.	Original article	Unincreased mortality of patients with early rheumatoid arthritis compared to the general population in the past 17 years: Analyses from the IORRA cohort 2024/02/26
2.	Original article	Impact of concomitant chronic kidney disease on hospitalised infections and remission in patients with rheumatoid arthritis: results from the IORRA cohort. 2022/08/20
3.	Original article	Trends in Risks of Malignancies in Japanese Patients with Rheumatoid Arthritis: Analyses from a 14-year Observation of the IORRA Cohort. 2022/08/03
4.	Original article	Differences in patients' population and efficacy/effectiveness of biologic disease-modifying antirheumatic drugs between randomized controlled trials and real-world settings in patients with rheumatoid arthritis - using the IORRA cohort. 2022/07/01
5.	Original article	Risk of herpes zoster in patients with rheumatoid arthritis in the biologics era from 2011 to 2015 and its association with methotrexate, biologics, and corticosteroids. 2022/04/18
6.	Original article	Successful discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis in real-world settings. 2021/07/04
7.	Original article	Successful discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis in real-world settings. 2021/07
8.	Original article	The minimally important difference for the Japanese version of the health assessment questionnaire in patients with rheumatoid arthritis in daily practice. 2017/05
9.	Original article	Characteristics and risk factors of lymphoproliferative disorders among patients with rheumatoid arthritis concurrently treated with methotrexate: a nested case-control study of the IORRA cohort. 2017/04
10.	Original article	Continual Maintenance of Remission Defined by the ACR/EULAR Criteria in Daily Practice Leads to Better Functional Outcomes in Patients with Rheumatoid Arthritis. 2017/02
11.	Original article	The minimally important difference for the Japanese version of the health assessment questionnaire in patients with rheumatoid arthritis in daily practice. 2016/10
12.	Original article	Pharmacoeconomic analysis of biological disease modifying antirheumatic drugs in patients with rheumatoid arthritis based on real-world data from the IORRA observational cohort study in Japan. 2016/07
13.	Original article	Profiles of EQ-5D utility scores in the daily practice of Japanese patients with rheumatoid arthritis; Analysis of the IORRA database. 2016
14.	Original article	Effect of Smoking on Remission Proportions Differs Between Male and Female Patients with Rheumatoid Arthritis: A Study Based on the IORRA Survey. 2015/07
15.	Original article	Cost-effectiveness of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, versus methotrexate in patients with rheumatoid arthritis using real-world data from the IORRA observational cohort study. 2015/03
16.	Original article	Effect of smoking on Remission Proportions Differs Between Male and Female Patients with Rheumatoid Arthritis:A Atudy Based on the IORRA Survey. 2015/03
17.	Original article	Presence of comorbidity affects both treatment strategies and outcomes in disease activity, physical function, and quality of life in patients with rheumatoid arthritis 2015/03
18.	Original article	Erythematosus plaques with macrophage infiltration as an initial manifestation of macrophage activation syndrome in a patient with systemic lupus erythematosus. 2014/07
19.	Original article	Functional disability can deteriorate despite suppression of disease activity in patients with rheumatoid arthritis: a large observational cohort study. 2013/11
Display 5 items
Display all(19)

■ Academic conference presentation

1.	Factors associated with treatment response in patients with elderly-onset rheumatoid arhthritis: 3-year observation using IORRA cohort 2020/08/04
2.	Factors associated with treatment response in patients with elderly-onset rheumatoid arhthritis: 3-year observation using IORRA cohort 2020/06/03
3.	The Incidence of Malignancies in Japanese patients with rheumatoid arthritis enrolled in the IORRA cohort during a 14-year observation period. 2015/06
4.	The minimally important difference in the European quality of life-five dimensions(EQ-5D) in patients with rheumatoid arthritis based on the Institute of Rheumatology, Rheumatoid Arthritis (IORRA) Cohort. 2014/11/16
5.	Treatment for Rheumatoid arthritis patients after a lymphoproliferative disorder. 2014/06/13